Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease

Endocrine

Volumn 42, Issue 3, 2012, Pages 739-741

  Yasuda, Tetsuyuki ^a   Okamoto, Yasuyuki ^b   Hamada, Noboru ^b   Miyashita, Kazuyuki ^a   Takahara, Mitsuyoshi ^a   Sakamoto, Fumie ^a   Miyatsuka, Takeshi ^a   Kitamura, Tetsuhiro ^a   Katakami, Naoto ^a   Kawamori, Dan ^a   Otsuki, Michio ^a   Matsuoka, Taka Aki ^a   Kaneto, Hideaki ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sumire Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; VITAMIN D; CALCIUM; PARATHYROID HORMONE; THYROGLOBULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FACTORIAL ANALYSIS; FEMALE; GRAVES DISEASE; HEALTH STATUS; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; PRIORITY JOURNAL; SYMPTOM; THYROID WEIGHT; VITAMIN BLOOD LEVEL; VITAMIN D BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; BODY MASS; ECHOGRAPHY; ENZYME IMMUNOASSAY; LETTER; PATHOLOGY; THYROID GLAND;

ADULT; BODY MASS INDEX; CALCIFEDIOL; CALCIUM; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; PARATHYROID HORMONE; THYROGLOBULIN; THYROID GLAND; THYROTROPIN; THYROXINE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84878229737     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9679-y     Document Type: Article

References (12)

1. F. Baeke, T. Takiishi, H. Korf, C. Gysemans, C. Mathieu, Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10(4), 482-496 (2010)
2. G. Tamer, S. Arik, I. Tamer, D. Coksert, Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 21(8), 891-896 (2011)
3. H. Pantazi, P.D. Papapetrou, Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J. Clin. Endocrinol. Metab. 85(3), 1099-1106 (2000)
4. N. Vilarrasa, J. Vendrell, J. Maravall, I. ElIo, E. Solano, P. San Jose, I. GarcIa, N. Virgili, J. Soler, J.M. Gomez, Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38(2), 235-242 (2010)
5. A.L. Ponsonby, A. Pezic, J. Ellis, R. Morley, F. Cameron, J. Carlin, T. Dwyer, Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am. J. Epidemiol. 168(4), 358-365 (2008)
6. J. Smolders, E. Peelen, M. Thewissen, P. Menheere, J.W. Tervaert, R. Hupperts, J. Damoiseaux, The prevalence of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun. Rev. 8(7), 621-626 (2009)
7. N. Naderi, A. Farnood, M. Habibi, F. Derakhshan, H. Balaii, Z. Motahari, M.R. Agah, F. Firouzi, M.G. Rad, R. Aghazadeh, H. Zojaji, M.R. Zali, Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J. Gastroenterol. Hepatol. 23(12), 1816-1822 (2008)
8. H. Zhou, C. Xu, M. Gu, Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis. Clin Endocrinol (Oxf) 70(6), 938-945 (2009)
9. A. Kurylowicz, E. Ramos-Lopez, T. Bednarczuk, K. Badenhoop, Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp. Clin. Endocrinol. Diabetes 114(6), 329-335 (2006)
10. A. Misharin, M. Hewison, C.R. Chen, V. Lagishetty, H.A. Aliesky, Y. Mizutori, B. Rapoport, S.M. McLachlan, Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology 150(2), 1051-1060 (2009)
11. E. Borgogni, E. Sarchielli, M. Sottili, V. Santarlasci, L. Cosmi, S. Gelmini, A. Lombardi, G. Cantini, G. Perigli, M. Luconi, G.B. Vannelli, F. Annunziato, L. Adorini, M. Serio, C. Crescioli, Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology 149(7), 3626-3634 (2008)
12. M. Rotondi, L. Chiovato, The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. Curr. Pharm. Des. 17(29), 3202-3216 (2011)